Cwm LLC Has $142,000 Stock Holdings in Embecta Corp. (NASDAQ:EMBC)

Cwm LLC lifted its holdings in shares of Embecta Corp. (NASDAQ:EMBC) by 11.3% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,102 shares of the company’s stock after buying an additional 1,023 shares during the period. Cwm LLC’s holdings in Embecta were worth $142,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of EMBC. SG Americas Securities LLC acquired a new position in Embecta during the third quarter worth about $207,000. Creative Planning acquired a new position in Embecta during the 2nd quarter worth approximately $454,000. Algert Global LLC lifted its stake in Embecta by 281.8% in the 2nd quarter. Algert Global LLC now owns 153,953 shares of the company’s stock valued at $1,924,000 after purchasing an additional 113,633 shares during the last quarter. Mackenzie Financial Corp boosted its position in Embecta by 40.4% in the second quarter. Mackenzie Financial Corp now owns 45,996 shares of the company’s stock valued at $575,000 after buying an additional 13,225 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Embecta by 4.8% during the second quarter. The Manufacturers Life Insurance Company now owns 22,212 shares of the company’s stock worth $278,000 after buying an additional 1,025 shares during the last quarter. 93.83% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Morgan Stanley cut their price objective on Embecta from $13.00 to $12.00 and set an “underweight” rating on the stock in a report on Monday, July 15th.

Embecta Trading Up 0.2 %

NASDAQ:EMBC opened at $14.05 on Friday. The stock’s 50-day moving average is $14.57 and its 200-day moving average is $13.40. Embecta Corp. has a 1-year low of $9.93 and a 1-year high of $19.79. The stock has a market cap of $810.26 million, a P/E ratio of 11.61 and a beta of 0.98.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings results on Friday, August 9th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.28. The company had revenue of $272.50 million for the quarter, compared to analyst estimates of $267.44 million. Embecta had a net margin of 6.23% and a negative return on equity of 19.09%. Embecta’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.69 earnings per share. As a group, equities analysts forecast that Embecta Corp. will post 2.43 EPS for the current year.

Embecta Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Tuesday, August 27th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Tuesday, August 27th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.27%. Embecta’s dividend payout ratio (DPR) is 49.59%.

About Embecta

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.